Randomized Controlled Trial on the Effects of Yiqi Fumai Keli on Recurrence in Patients with Atrial Fibrillation after Radiofrequency Ablatio
- Conditions
- atrial fibrillation
- Registration Number
- ITMCTR2000003986
- Lead Sponsor
- Dongfang Hospital, Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) The patients met the diagnostic criteria of atrial fibrillation and underwent radiofrequency ablation successfully;
(2) TCM syndrome differentiation is in accordance with Qi deficiency and blood stasis, phlegm heat disturbing heart syndrome;
(3) Aged 18-80 years old;
(4) Volunteer to participate and sign informed consent.
(1) Severe structural heart disease, heart failure (LVEF <=40%), serious arrhythmia such as persistent ventricular tachycardia;
(2) Thyroid disease, severe liver and kidney disease, mental illness and malignant tumor, pregnant women and breast-feeding;
(3) Participants in other clinical trials within 3 months;
(4) Patients who used other antiarrhythmic Chinese patent medicines and their preparations.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence rate of atrial fibrillation;
- Secondary Outcome Measures
Name Time Method TCM Syndrome Evaluation;